Overview

Crossover Post-herpetic Neuralgia (PHN)

Status:
Completed

Trial end date:
2012-06-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the efficacy of study drug (BMS-954561) as compared to placebo in the treatment of patients with post-herpetic neuralgia (PHN).

Phase:

Phase 2

Details

Lead Sponsor:

Bristol-Myers Squibb